AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2014

Dec 10, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2014-12-09

Reporting Person: Foster-Cheek Kaye I (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-09	Stock Option (right to buy)	$110.56	A	25000	Acquired	2024-12-08	Common stock (25000)	Direct

Footnotes

F1: This option was granted on December 9, 2014. The shares underlying this option vest as to 25% of the underlying shares on December 9, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter.